Combination of Immune Checkpoint Inhibitors and Liver-Specific Therapies in Liver-Metastatic Uveal Melanoma: Can We Thus Overcome Its High Resistance? by Chiara L. Blomen, Julian Kött, Tabea I. Hartung, Leopold K. Torster, Christoffer Gebhardt

Get full text

Emerging precision diagnostics in advanced cutaneous squamous cell carcinoma by Glenn Geidel, Isabel Heidrich, Julian Kött, Stefan W. Schneider, Klaus Pantel, Christoffer Gebhardt

Get full text

Patient-reported treatment outcomes and safety of direct-to-consumer teledermatology for finasteride treatment in male androgenetic alopecia: A cross-sectional study by Johannes von Büren, Inga Hansen, Julian Kött, Florian Schröder, Juliana Veneroso, Stefan W. Schneider, Finn Abeck

Get full text

Successful treatment of refractory checkpoint inhibitor‐induced hepatitis with quadruple therapy including extracorporeal photopheresis and infliximab by Inga Hansen, Julian Kött, Silke Heidenreich, Francis A. Ayuk, Patricia Doll, Finn Abeck, Nina Booken, Christoffer Gebhardt, Stefan W. Schneider

Get full text

Activated Eosinophils Predict Longer Progression-Free Survival under Immune Checkpoint Inhibition in Melanoma by Nadine L. Ammann, Yasmin F. Schwietzer, Christian Mess, Julia-Christina Stadler, Glenn Geidel, Julian Kött, Klaus Pantel, Stefan W. Schneider, Jochen Utikal, Alexander T. Bauer, Christoffer Gebhardt

Get full text